IRMD
IRadimed Corporation
NASDAQ · USHealthcareMedical - Devices
$97.03+0.00%
Price as of Jul 20, 2026
IRMD valuation
IRadimed Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 44.31x
- P/E 2026E
- 46.50x
- P/E 2027E
- 41.69x
- P/E 2028E
- —
- P/S forward
- 12.79x
Trailing multiples
- P/E TTM
- 52.17x
- PEG TTM
- 2.93x
- Price / book
- 12.59x
- Price / sales
- 14.38x
- Price / cash flow
- 42.85x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 13.72x
- EV / EBITDA
- 36.73x
- EV / EBIT
- 42.36x
- Market cap
- $1.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.